Hypertension is the most common chronic cardiovascular condition, with an increasing prevalence all over the world. Patients with refractory hypertension are the group most at risk for adverse cardiovascular events, but also present a particular diagnostic and therapeutic challenge. The present article reviews the mechanisms of development of resistant hypertension and the possibilities of pharmacological treatment and interventional approaches.
Keywords: mineralocorticoid receptor blocker; renal artery angioplasty; renal denervation; resistant hypertension; carotid baroreceptor stimulation.